Phylomer peptides (PYC Therapeutics/MedImmune)

N/A

Report date: 2025/03/20 14:42:46
NME

Base Information

Drug NamePhylomer peptides (PYC Therapeutics/MedImmune)
Drug Alias NamePhylomer peptides (Phylogica/MedImmune)
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > AntibioticsNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPYC Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune LlcPYC Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A